R & D is a part of our strategy to become and integrated pharma in India. We believe R & D is of critical importance in our need to grow in the area of biotechnology and original drug research.
The aim here is to revise formulation and dosage form new drug to be introduced and makes variants of particular dosage form
The development of new delivery system like nanoparticles and controlled drug.
Maxicon is driven by it vision to achieve significant business in proprietary prescription products with a strong presence in the pharma market. Achieving customer satisfaction is fundamental to our business.
One of our key has been to develop indigenous processes for new drugs introduced in the developing countries , produce and introduce them in lots of countries and promptly supply them to non-regulatory markets.
Copyright © 2022 | Design & Developed by EncodeZero